https://yourhealthrx.us/blog/ Plain-English education on peptide therapy, compounded medications, GLP-1s, and the regulatory landscape — written for patients who want to understand the science before starting a protocol. Available to patients in all 50 states and DC. en-us Copyright 2026 YourHealthRx. All rights reserved. Wed, 06 May 2026 16:00:00 -0400 https://yourhealthrx.us/blog/compounded-vs-brand-glp-1s-2026-guide/ https://yourhealthrx.us/blog/compounded-vs-brand-glp-1s-2026-guide/ Wed, 06 May 2026 16:00:00 -0400 The post-shortage landscape for GLP-1 medications changed fundamentally in early 2025. This plain-English guide explains the full regulatory timeline, when compounded semaglutide and tirzepatide are still legal in 2026, when they are not, and how to evaluate your options with your clinician. GLP-1 compounded-semaglutide compounded-tirzepatide compounding education semaglutide tirzepatide https://yourhealthrx.us/blog/the-middle-path-for-peptide-therapy/ https://yourhealthrx.us/blog/the-middle-path-for-peptide-therapy/ Wed, 06 May 2026 16:00:00 -0400 Patients exploring peptide therapy face a false binary: unregulated grey-market peptides on one end, thousand-dollar-a-month brand drugs on the other. The middle path — licensed clinician oversight, 503A-compliant compounding, and evidence-based protocols — is what appropriate care actually looks like. peptide-therapy compounding education 503A GLP-1-telehealth